Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment
Author:
Publisher
Elsevier BV
Subject
Urology
Reference14 articles.
1. American Urological Association. The management of erectile dysfunction. www.auanet.org/education/guidelines/erectile-dysfunction.cfm
2. Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy;Michl;J Urol,2015
3. A Detailed analysis of the association between postoperative phosphodiesterase type 5 inhibitor use and the risk of biochemical recurrence after radical prostatectomy;Gallina;Eur Urol,2015
4. Cohort profile: the national prostate cancer register of Sweden and prostate cancer database Sweden 2.0;Van Hemelrijck;Int J Epidemiol,2013
5. A contemporary prostate cancer grading system: a validated alternative to Gleason score;Epstein;Eur Urol,2016
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration;Interdisciplinary Medicine;2024-03-16
2. Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?;Journal of Urology;2024-03
3. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health;The Journal of Sexual Medicine;2023-12-26
4. Medical and Surgical Management of Erectile Dysfunction;Men's Reproductive and Sexual Health Throughout the Lifespan;2023-11-16
5. Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients;The World Journal of Men's Health;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3